Drug Shortage Report for PULMICORT TURBUHALER
Report ID | 257183 |
Drug Identification Number | 00851752 |
Brand name | PULMICORT TURBUHALER |
Common or Proper name | BUDESONIDE |
Company Name | ASTRAZENECA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 200MCG |
Dosage form(s) | POWDER (METERED DOSE) |
Route of administration | INHALATION INHALATION |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 1 INHALER |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2025-10-01 |
Actual start date | |
Estimated end date | 2025-12-15 |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2025-08-07 |
Company comments | TESTING 123 |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: [email protected]. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2025-08-07 | French | Compare |
v3 | 2025-08-07 | English | Compare |
v2 | 2025-08-07 | English | Compare |
v1 | 2025-08-07 | English | Compare |
Showing 1 to 4 of 4